One of the top 50 start ups in french-speaking Switzerland

Dec 19, 2019
1 min read

Geneva, Switzerland, December 18, 2019 – Abologix is profiled in the leading swiss Business magazine “Bilan” as one of the most promissing start ups in Suisse Romande. The company has been invited to present its investment case in a future event sponsored by “Bilan” to be held in Lausanne, Switzerland.

Abologix obtains funding from the KICK FUND

Geneva, Switzerland, December 23, 2024 – Abologix has been awarded 100,000 CHF by the KICK FUND to progress its advanced preclinical...

Successful completion of the Innosuisse Innovation Project

Geneva, Switzerland, November 23, 2023 – Abologix successfully completes the Innosuisse-funded program for the initial characterization...

Nomination of product H225 as the lead preclinical candidate

Geneva, Switzerland, December 20, 2022 – Abologix nominates monoclonal antibody H225 (blocker of JAM-C, Junction Adhesion Molecule C) as...

One of the top 50 start ups in french-speaking Switzerland

Comments

Back to Top